Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021

Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo

Rian SnijdersComments to Author , Alain Fukinsia, Yves Claeys, Epco Hasker, Alain Mpanya, Erick Miaka, Filip Meheus, and Marleen Boelaert1
Author affiliations: Swiss Tropical and Public Health Institute, Basel, Switzerland (R. Snijders); University of Basel, Basel (R. Snijders); Institute of Tropical Medicine, Antwerp, Belgium (R. Snijders, Y. Claeys, E. Hasker, M. Boelaert); Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Democratic Republic of the Congo (A. Fukinsia, A. Mpanya, E. Miaka); International Agency for Research on Cancer, Lyon, France (F. Meheus)

Main Article

Table 2

Annual economic costs of passive human African trypanosomiasis screening in Mosango and Yasa Bonga health districts, Democratic Republic of the Congo*

Cost category and subcategory Description Cost, USD
Total, %
Mosango Yasa Bonga Total
Capital equipment 18,008 25,051 43,060 25
Equipment Confirmation equipment 4,734 6,627 11,360 7
  Laboratory equipment 2,539 3,554 6,093 4
  Nonmedical equipment 2,195 3,073 5,268 3
Training HAT diagnosis training 13,275 18,424 31.699 19
  Screening 5,079 6,950 12,029 7

Annual recurrent costs 69,243 56,764 126,008 75
Laboratory and medical supplies HAT tests 7,487 5,449 12,262 7
  RDTs 7,388 4,874 12,262 7
  Microscopy 99 575 673 0.4
Patient care Staging and inpatient and outpatient care 413 1,601 2,014 1
HR and infrastructure use Execution RDT 36,535 24,102 60,637 36
Management and supervision

Cost per person screened 7.95 11.29 9.28
Cost per case diagnosed and treated
21,813 3,557 6,262

*HAT, human African trypanosomiasis; HR, human resources; RDT, rapid diagnostic test.

Main Article


Page created: June 10, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.